Gradient Investments’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-67
Closed -$6.19K 626
2024
Q2
$6.19K Buy
67
+16
+31% +$1.48K ﹤0.01% 822
2024
Q1
$4.87K Sell
51
-584
-92% -$55.8K ﹤0.01% 729
2023
Q4
$48.4K Sell
635
-575
-48% -$43.8K ﹤0.01% 545
2023
Q3
$83.8K Buy
1,210
+975
+415% +$67.5K ﹤0.01% 418
2023
Q2
$22.2K Buy
235
+55
+31% +$5.19K ﹤0.01% 669
2023
Q1
$14.9K Hold
180
﹤0.01% 727
2022
Q4
$13.4K Hold
180
﹤0.01% 756
2022
Q3
$15K Sell
180
-38
-17% -$3.17K ﹤0.01% 716
2022
Q2
$21K Buy
218
+45
+26% +$4.34K ﹤0.01% 637
2022
Q1
$20K Hold
173
﹤0.01% 649
2021
Q4
$22K Hold
173
﹤0.01% 635
2021
Q3
$20K Buy
173
+13
+8% +$1.5K ﹤0.01% 641
2021
Q2
$17K Hold
160
﹤0.01% 663
2021
Q1
$13K Buy
+160
New +$13K ﹤0.01% 705
2020
Q1
Sell
-6
Closed 1129
2019
Q4
$0 Hold
6
﹤0.01% 1132
2019
Q3
$0 Buy
+6
New ﹤0.01% 1138
2019
Q1
Sell
-315
Closed -$16K 901
2018
Q4
$16K Sell
315
-132
-30% -$6.71K ﹤0.01% 488
2018
Q3
$26K Sell
447
-17,826
-98% -$1.04M ﹤0.01% 448
2018
Q2
$887K Buy
18,273
+2,244
+14% +$109K 0.05% 154
2018
Q1
$745K Buy
16,029
+2,184
+16% +$102K 0.04% 146
2017
Q4
$520K Buy
13,845
+3,807
+38% +$143K 0.03% 174
2017
Q3
$366K Buy
10,038
+366
+4% +$13.3K 0.02% 192
2017
Q2
$381K Buy
9,672
+498
+5% +$19.6K 0.03% 181
2017
Q1
$288K Buy
+9,174
New +$288K 0.02% 174
2014
Q1
Sell
-204
Closed -$2K 561
2013
Q4
$2K Buy
+204
New +$2K ﹤0.01% 505